Physics of Plasmas is a premier peer-reviewed journal published by AIP Publishing, focusing on the vital and interdisciplinary field of plasma physics. With an ISSN of 1070-664X, this journal presents cutting-edge research that spans a wide array of topics including fusion energy, astrophysical plasmas, and industrial applications of plasma technologies. As a recognized leader in the field, it holds a prestigious Q1 ranking in Condensed Matter Physics, reflecting its high impact and quality of published work. The journal's scope encompasses both fundamental studies and innovative applications, serving as an essential resource for researchers, professionals, and students alike. Although it does not offer open access, its rigorous selection process ensures that only the most significant contributions are highlighted. With a convergence of expertise from 1994 to 2024, Physics of Plasmas continually shapes the future of plasma research and technology, making it a critical avenue for sharing discoveries and advancements in this dynamic area of physics.

THERAPEUTIC APHERESIS AND DIALYSIS is an esteemed journal published by Wiley, focusing on the fields of hematology and nephrology. Since its inception in 2003, the journal has provided a dedicated platform for research and advancements in therapeutic apheresis and dialysis methodologies, offering valuable insights for clinicians and researchers alike. With an ISSN of 1744-9979 and an E-ISSN of 1744-9987, the journal has established itself within Q3 in both the hematology and nephrology categories. Its Scopus rankings place it at #44 in nephrology and #79 in hematology, indicating its growing influence in these critical areas of medical research. Although it does not currently offer open access, THERAPEUTIC APHERESIS AND DIALYSIS remains a vital resource for professionals aiming to stay at the forefront of innovations and practices through 2024 and beyond. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and discussions presented within its pages, solidifying its role in enhancing patient care and therapeutic strategies.

Plasma Processes and Polymers is a leading peer-reviewed journal published by WILEY-V C H VERLAG GMBH, focusing on the innovative field of plasma science and polymer technology since its inception in 2004. With an ISSN of 1612-8850 and an E-ISSN of 1612-8869, this journal has established its reputation within the scientific community, holding a commendable Q2 ranking in both Condensed Matter Physics and Polymers and Plastics for 2023. Recognized for its rigorous standards and impactful contributions to the field, it ranks in the top 20% of the Physics and Astronomy category and top 26% of the Materials Science category, as per Scopus metrics. Catering to researchers, professionals, and students alike, the journal publishes cutting-edge articles that advance understanding and application of plasma processes in polymer science, thereby bridging theoretical insights with practical implications. While currently not offering open access, it provides a critical platform for advancing knowledge and fostering innovation, making it essential reading for those at the forefront of polymer research and applications.

Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.

The Journal of Blood Medicine, published by DOVE MEDICAL PRESS LTD, stands as a vital resource in the field of hematology, focusing on the latest research developments and clinical advancements in blood medicine. With an impact factor reflective of its growing relevance, this open-access journal has been delivering quality scholarly work since 2010, ensuring that critical research is readily available to the global scientific community. The journal operates under an open-access model, further enhancing its dissemination and accessibility to researchers, professionals, and students alike. In the 2023 rankings, it secured a Q3 category status within hematology and achieved a commendable 76th rank out of 137 in Scopus listings, indicating its commitment to quality and innovation in this specialized area. Located in New Zealand, the journal's diverse topics encompass clinical research, treatment modalities, and emerging therapies, contributing significant insights vital for shaping future advancements in blood medicine.

PTERIDINES is a unique journal dedicated to the study of pteridines and their implications in biochemistry and clinical research. Published by DE GRUYTER POLAND SP Z O O, this Open Access journal has been a vital resource since its inception in 1989, steadily evolving to include a diverse range of topics pertinent to molecular medicine and biochemistry. With its current classification in the Q4 quartile for Biochemistry, Clinical Biochemistry, and Molecular Medicine, PTERIDINES offers a platform for researchers and professionals seeking to disseminate and access groundbreaking findings. Although the journal has a modest Scopus ranking, it serves as an important outlet for both emerging and established scholars in the field, particularly those focusing on the biochemical roles of pteridines. Based in Germany, the journal invites contributions from around the globe, providing equitable access to all readers since 2018, making significant strides towards inclusive scientific discourse. As such, PTERIDINES is a valuable asset for anyone engaged in the exploration of pteridines and their multifaceted roles in health and disease.

Experimental Hematology & Oncology is a premier journal published by BMC, dedicated to advancing knowledge in the fields of hematology, oncology, and cancer research. Since its inception in 2012, this Open Access journal has emerged as a vital resource for researchers and healthcare professionals, fostering the dissemination of high-quality research that enhances our understanding of blood disorders and malignancies. With impressive rankings in Quarters 1 of key categories including Cancer Research, Hematology, and Oncology, it holds significant prestige, evidenced by its Scopus rankings: #42/404 in Medicine (Oncology) and #17/137 in Medicine (Hematology). The journal aims to publish cutting-edge studies, reviews, and perspectives that contribute to the evolution of therapeutic strategies and innovative treatment modalities. Researchers and practitioners alike will find this journal indispensable for staying at the forefront of breakthroughs in hematological and oncological research.

Plasma and Fusion Research is a pivotal journal within the realm of plasma science and nuclear fusion, published by the Japan Society of Plasma Science and Nuclear Fusion Research. With an ISSN of 1880-6821, this journal serves as a vital platform for disseminating significant research findings and advancements from Japan and around the globe. Operating since 2006, it has steadily contributed to the field, reflected in its recognition as a Q3 journal in Condensed Matter Physics for the year 2023 and its ranking of #383 out of 434 in the Scopus categories, placing it in the 11th percentile. Although it currently does not offer open access, the journal's commitment to quality research makes it essential reading for researchers, professionals, and students keen on exploring the complexities of plasma dynamics, fusion technology, and their applications in energy production. Situated in Nagoya, Japan, the journal fosters a collaborative environment aimed at pushing the boundaries of knowledge in plasma physics and enhancing the understanding of fusion processes.

Plasma is a leading open-access journal published by MDPI, devoted to the exploration and advancement of knowledge in the fields of engineering, physics, and materials science. Established in 2018, this journal provides a vital platform for researchers, professionals, and students to disseminate original findings and critical reviews related to plasma science, its applications, and its interdisciplinary aspects. With an E-ISSN of 2571-6182, Plasma actively promotes open access to ensure that research is widely accessible, reinforcing its commitment to accelerating scientific communication and collaboration across global communities. The journal enjoys respectable rankings in Scopus, with a notable position in Engineering, Physics and Astronomy, and Materials Science categories, making it an essential resource for those seeking to remain at the forefront of plasma research. Covering a range of topics until 2024, Plasma invites cutting-edge contributions that push the boundaries of understanding in this dynamic field.

Lancet Haematology, published by Elsevier Science Ltd in the United Kingdom, is a premier peer-reviewed journal dedicated to advancing the field of hematology. With an impressive impact factor and listed in the Q1 category in hematology for 2023, this journal ranks #4 out of 137 in the Scopus database, boasting a 97th percentile indicating its influential role in disseminating high-quality research. Since its establishment in 2014, Lancet Haematology has provided a vital platform for researchers and clinicians to share groundbreaking studies, innovative treatment approaches, and novel therapeutic discoveries relevant to various hematological disorders. The journal does not operate under an open access model, but it offers multiple access options to facilitate engagement with its content. By bridging clinical practice and cutting-edge research, Lancet Haematology aims to foster the advancement of knowledge and improve patient outcomes in hematology, making it an essential read for professionals, researchers, and students alike.